GLP-1 weight loss injection syringes next to a measuring tape, representing semaglutide and tirzepatide advertising rules
Prescription weight loss is a booming service, but the ad platforms gate it hard. Photo via Pexels.

Demand for GLP-1 weight loss medications has gone from niche to mainstream in about two years. A KFF poll found roughly 1 in 8 US adults say they have taken a GLP-1 drug like semaglutide or tirzepatide. Med spas, family medicine offices, and telehealth clinics all added a weight loss line because patients are asking for it by name. So you set up a Google or Meta campaign, write a clean ad, and within a day it is disapproved. Try again, and now your whole account is under review.

You did nothing shady. You ran into the single biggest rule in healthcare advertising that almost no one tells you about until it bites: prescription weight loss drugs are gated. Here is what that gate is, and how to get through it the right way.

1 in 8 US adults say they have taken a GLP-1 drug like semaglutide or tirzepatide. Demand is real, but so are the ad rules that come with it. Source: KFF Health Tracking Poll, 2024.

The short answer: yes, but you need certification first

You can absolutely advertise a GLP-1 or medical weight loss program on Google and Meta. What you cannot do is advertise it as an ordinary business. Both platforms classify prescription medications as restricted, and both require a third party stamp of approval called LegitScript certification before your ads for those drugs will run. No certification, no prescription drug ads. That is the wall most clinics hit without knowing it exists.

LegitScript is an independent company that verifies a healthcare provider or pharmacy is operating legally and safely. Google, Meta, and Bing all recognize it. Think of it as a background check for your practice that the ad platforms trust so they do not have to run one themselves. You can see the details on the LegitScript healthcare certification page. It usually takes about four to eight weeks to get approved and carries a registration fee plus ongoing costs, so it is worth starting early rather than after your ads are already dead.

What Google actually requires

Google treats words like semaglutide, tirzepatide, phentermine, and compounded weight loss injections as restricted drug terms under its healthcare and medicines policy. Only LegitScript certified advertisers can target those terms, and your ads, keywords, and landing pages all have to line up with the policy. Reference a prescription drug or a telehealth consult for one without certification, and the ad gets rejected. Push it, and the account can get suspended, which is a far worse problem than a single disapproved ad.

There is a subtle trap here for clinics that try to be clever. Some owners strip the drug names out of the ad and just say "medical weight loss" to sneak past the filter, then send clicks to a landing page that talks about semaglutide. Google reads the landing page too. A compliant ad pointing at a non compliant page still gets you flagged. The whole funnel has to match, which is exactly why practices ask us whether their practice is even ready to run ads before they spend a dollar.

What Meta requires, and the body image rules on top

Meta runs a similar gate. Prescription weight loss ads fall under its Drugs and Pharmaceuticals policy, which means written permission and, in practice, the same LegitScript certification, plus geo targeting limited to allowed regions. But Meta adds a second layer that trips up even certified advertisers, and it has nothing to do with the drug itself. It is about how you talk about bodies.

Under Meta's health and wellness ad standards, you cannot run ads that imply or try to generate a negative self perception. No shaming the viewer about their weight, no fear based messaging aimed at insecurities, no "are you embarrassed by your body" angle. These ads also have to be targeted to people 18 and older. As of a July 2026 update, Meta stopped automatically rejecting every side by side before and after image, but exaggerated results and shame based framing still get pulled fast. The safest creative sells the outcome and the support, not the shame.

The three gates, in order

Before a single GLP-1 ad runs, it has to clear all three: 1) LegitScript certification so the platform will accept prescription drug ads at all. 2) The platform policy from Google or Meta on how the ad, keywords, and landing page are written. 3) FTC claim rules on what you are allowed to promise. Miss any one and the campaign fails, usually without a clear reason in the disapproval notice.

The FTC layer everyone forgets

Even with certification and a clean platform review, there is a federal regulator watching the claims themselves. The Federal Trade Commission has chased deceptive weight loss advertising for decades, and it publishes a plain list of promises it treats as automatically false. Its Gut Check guidance flags claims like losing a lot of weight with no diet or exercise, losing weight no matter what or how much you eat, blocking the absorption of fat or calories, and results that are permanent or work for everybody. If your ad says any of that, it is deceptive, full stop, regardless of what Google or Meta let through.

For a real medical weight loss practice, this is good news. You have honest, defensible outcomes to talk about. You do not need the miracle language, and the miracle language is exactly what gets both the platforms and the FTC on your case. Sell the actual program: medical supervision, a real provider, realistic results, ongoing support.

The compounding wrinkle in 2026

One more piece that changed the landscape. When branded GLP-1 drugs were in shortage, many clinics sold compounded versions. The FDA declared the semaglutide and tirzepatide shortages resolved in 2025, which sharply narrowed when mass compounding is legal. That matters for advertising because you can only promote what you can lawfully provide. If your weight loss offer leans on compounded product, get clear guidance on what you are allowed to dispense today before you build ads around it, because the platforms and regulators are both paying closer attention to this exact category now.

What to do while you get certified

Here is the part that saves clinics who are stuck in the four to eight week certification window, or who do not want to depend on paid ads at all. The restricted channels are not the only way to reach patients searching for weight loss help. In many local markets they are not even the best way.

None of these turn off the day you stop paying, which is the real advantage. Ads are rent. The moment the budget stops, the patients stop the same day. Your SEO, your reviews, and your content keep bringing people in for years. The smartest weight loss practices run both, so paid ads scale what an already working foundation is doing.

Where EtherealMinds fits

We work only with healthcare practices across the United States, and medical weight loss is one of the toughest categories to advertise cleanly, which is exactly why we like it. We help clinics get the compliance pieces in order, build ad funnels where the creative, keywords, and landing pages all pass review together, and pair that with the organic patient acquisition system that keeps working whether or not any single ad is live. No banned accounts, no miracle claims, no scramble when a policy changes.

If your GLP-1 ads keep getting rejected and no one at the platform will tell you why, it is almost never bad luck. It is one of these three gates. Fix the gate, and the same offer that got shut down yesterday can run clean and profitable tomorrow.

Get your weight loss ads running the right way

Book a free strategy call. We will look at why your GLP-1 or semaglutide ads are getting rejected, walk you through the certification and compliance steps, and map a plan that brings in weight loss patients through both paid and organic. Clear, honest, no jargon.

Book a free strategy call →